Werewolf Therapeutics ( (HOWL) ) just unveiled an update. Werewolf Therapeutics is pioneering the development of innovative cytokine therapies ...
El Mundo on MSN13h
CAR-T therapy offers hope against an incurable brain tumor: patient shows no sign of disease after four yearsIn a trial with 11 patients with midline diffuse glioma, 9 showed benefits from the cellular therapy. In one case, the tumor ...
The immune system is there to help us fight infection, but sometimes it wreaks more havoc than the disease itself. Sarah Bradley is a freelance writer with six years of experience creating ...
Preclinical data demonstrate the ability of p300 KAT inhibition to modulate multiple pro-inflammatory signaling pathways, including antibodies ...
All patients experienced treatment-emergent adverse events, Adaptimmune said. The most common adverse events were cytopenias, ...
Researchers advance CAR T cell therapy for solid tumors by innovating ways to overcome the unique barriers of solid tumor ...
Following strong treatment response data for Adaptimmune’s lete-cel, the biotech is planning to initiate a rolling BLA ...
Real-world results may differ from those seen in clinical trials for CAR T-cell therapy and bispecific antibodies for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback